263 related articles for article (PubMed ID: 11415941)
1. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
Rooney CP; Taggart C; Coakley R; McElvaney NG; O'Neill SJ
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):747-54. PubMed ID: 11415941
[TBL] [Abstract][Full Text] [Related]
2. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies.
van Rossum AP; Rarok AA; Huitema MG; Fassina G; Limburg PC; Kallenberg CG
J Leukoc Biol; 2004 Dec; 76(6):1162-70. PubMed ID: 15331626
[TBL] [Abstract][Full Text] [Related]
3. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
[TBL] [Abstract][Full Text] [Related]
5. c-ANCA-induced neutrophil-mediated lung injury: a model of acute Wegener's granulomatosis.
Hattar K; Oppermann S; Ankele C; Weissmann N; Schermuly RT; Bohle RM; Moritz R; Krögel B; Seeger W; Grimminger F; Sibelius U; Grandel U
Eur Respir J; 2010 Jul; 36(1):187-95. PubMed ID: 20032014
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
[TBL] [Abstract][Full Text] [Related]
7. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
van Rossum AP; Limburg PC; Kallenberg CG
Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939
[TBL] [Abstract][Full Text] [Related]
8. Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation.
Hattar K; Bickenbach A; Csernok E; Rosseau S; Grandel U; Seeger W; Grimminger F; Sibelius U
J Leukoc Biol; 2002 Jun; 71(6):996-1004. PubMed ID: 12050185
[TBL] [Abstract][Full Text] [Related]
9. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors.
Ralston DR; Marsh CB; Lowe MP; Wewers MD
J Clin Invest; 1997 Sep; 100(6):1416-24. PubMed ID: 9294107
[TBL] [Abstract][Full Text] [Related]
11. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
12. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
Gross WL; Csernok E; Flesch BK
J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
[TBL] [Abstract][Full Text] [Related]
13. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation.
Hattar K; van Bürck S; Bickenbach A; Grandel U; Maus U; Lohmeyer J; Csernok E; Hartung T; Seeger W; Grimminger F; Sibelius U
J Leukoc Biol; 2005 Oct; 78(4):992-1000. PubMed ID: 16006536
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
Daouk GH; Palsson R; Arnaout MA
Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
Surmiak M; Kaczor M; Sanak M
J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
[TBL] [Abstract][Full Text] [Related]
17. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
18. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
Hu N; Westra J; Kallenberg CG
Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
[TBL] [Abstract][Full Text] [Related]
19. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
[TBL] [Abstract][Full Text] [Related]
20. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis.
Baslund B; Szpirt W; Eriksson S; Elzouki AN; Wiik A; Wieslander J; Petersen J
Eur J Clin Invest; 1996 Sep; 26(9):786-92. PubMed ID: 8889441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
